Xylem Inc. $XYL Shares Acquired by Covea Finance

Covea Finance grew its stake in Xylem Inc. (NYSE:XYL) by 25.5% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 231,547 shares of the industrial products company’s stock after acquiring an additional 47,000 shares during the period. Xylem comprises 1.2% of Covea Finance’s investment portfolio, making the stock its 25th biggest holding. Covea Finance owned approximately 0.10% of Xylem worth $34,153,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in XYL. Maseco LLP acquired a new position in Xylem during the second quarter worth $31,000. ST Germain D J Co. Inc. lifted its stake in Xylem by 950.0% during the 2nd quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock worth $33,000 after acquiring an additional 228 shares in the last quarter. Signature Resources Capital Management LLC purchased a new position in Xylem during the 2nd quarter valued at about $39,000. Caldwell Trust Co acquired a new position in Xylem in the 2nd quarter valued at about $41,000. Finally, FWL Investment Management LLC purchased a new stake in Xylem during the second quarter worth about $43,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Stock Performance

Shares of XYL stock opened at $138.74 on Friday. The company has a market cap of $33.78 billion, a P/E ratio of 35.67, a PEG ratio of 2.15 and a beta of 1.18. The firm has a fifty day moving average price of $143.35 and a 200 day moving average price of $139.69. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $154.27.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. The company had revenue of $2.27 billion during the quarter, compared to the consensus estimate of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.Xylem’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.11 EPS. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Sell-side analysts predict that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend was Tuesday, November 25th. Xylem’s dividend payout ratio is 41.13%.

Insider Buying and Selling

In related news, Director Victoria D. Harker sold 1,700 shares of the company’s stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total value of $251,838.00. Following the completion of the transaction, the director directly owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction that occurred on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the sale, the executive vice president directly owned 31,250 shares in the company, valued at approximately $4,770,000. The trade was a 25.01% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on XYL. Barclays raised their price objective on shares of Xylem from $165.00 to $172.00 and gave the company an “overweight” rating in a research note on Wednesday, October 29th. Citigroup boosted their price target on shares of Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Xylem in a research report on Monday, December 15th. Argus set a $170.00 target price on Xylem in a report on Wednesday, October 29th. Finally, Mizuho set a $160.00 target price on Xylem in a research note on Wednesday, October 29th. Eight equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $167.40.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.